Thierry Lecomte


Ontology type: schema:Person     


Person Info

NAME

Thierry

SURNAME

Lecomte

Publications in SciGraph latest 50 shown

  • 2021-10-05 Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2021-08-05 Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model in CLINICAL PHARMACOKINETICS
  • 2021-04-13 The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program in TARGETED ONCOLOGY
  • 2021-03-26 Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort in BRITISH JOURNAL OF CANCER
  • 2021-01-20 Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases in ANNALS OF SURGICAL ONCOLOGY
  • 2018-06-14 Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma in BRITISH JOURNAL OF CANCER
  • 2018-05-17 Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-12-13 Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration in CLINICAL PHARMACOKINETICS
  • 2017-11-23 Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study in BRITISH JOURNAL OF CANCER
  • 2017-10-27 Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity in SCIENTIFIC REPORTS
  • 2017-10-12 Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma in BRITISH JOURNAL OF CANCER
  • 2017-09-25 « Une semaine de coloscopie en France » : résultats 2017 de l’enquête annuelle de la Société française d’endoscopie digestive in ACTA ENDOSCOPICA
  • 2017-06-29 Management of gastric neuro-endocrine tumours in a large French national cohort (GTE) in ENDOCRINE
  • 2017-06-20 Recommandations : cancers superficiels du tube digestif. Prise en charge endoscopique des cancers superficiels de l’estomac in ACTA ENDOSCOPICA
  • 2017-03-27 A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen in BMC CANCER
  • 2017-01-19 Actualités en cancérologie digestive à l’UEGW 2016 in ACTA ENDOSCOPICA
  • 2016-09-19 Recommandations du CDU–HGE, du CNU d’HGE et de la SFED sur la formation en endoscopie digestive in ACTA ENDOSCOPICA
  • 2016-06-16 Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients in CLINICAL PHARMACOKINETICS
  • 2016-06-02 La coloscopie en 2015 : de la préparation au diagnostic. Résultats de l’enquête annuelle de la Société Française d’Endoscopie Digestive in ACTA ENDOSCOPICA
  • 2016-02-23 What is the Best Colonoscopy Surveillance for Lynch Syndrome Patients? in CURRENT COLORECTAL CANCER REPORTS
  • 2016-01-29 Prévention du cancer colorectal par coloscopie, en dehors du dépistage en population. Consensus et position de la SFED in ACTA ENDOSCOPICA
  • 2015-11-28 Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology in QUALITY OF LIFE RESEARCH
  • 2015-09-15 Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort in BRITISH JOURNAL OF CANCER
  • 2015-09-15 A robust estimation of infliximab pharmacokinetic parameters in Crohn’s disease in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2015-09-04 Quelles évolutions dans la pratique et les résultats de la coloscopie entre 2011 et 2013 ? Résultats des enquêtes SFED : « une semaine d’endoscopie en France » in ACTA ENDOSCOPICA
  • 2015-01-20 Impact of Chromoscopy on Adenoma Detection in Patients With Lynch Syndrome: A Prospective, Multicenter, Blinded, Tandem Colonoscopy Study in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2014-12-12 Place des prothèses coliques dans la prise en charge du cancer colorectal in ONCOLOGIE
  • 2014-07-04 Place des prothèses coliques dans la stratégie thérapeutique du cancer colorectal in CÔLON & RECTUM
  • 2014-06-14 FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study in BMC CANCER
  • 2014-05-26 Prévention du cancer de l’estomac in ACTA ENDOSCOPICA
  • 2014-05-17 Prévention du cancer de l’anus in ACTA ENDOSCOPICA
  • 2014-03-13 Place des prothèses coliques dans la stratégie thérapeutique du cancer colorectal in ACTA ENDOSCOPICA
  • 2013-11-05 Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study in BRITISH JOURNAL OF CANCER
  • 2013-09-06 Comment défendre le point de vue de l’endoscopiste dans une réunion de concertation pluridisciplinaire ? in ACTA ENDOSCOPICA
  • 2013-07-13 Chimiothérapie (néo)adjuvante du cancer colique in CÔLON & RECTUM
  • 2013-06-07 Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins in MOLECULAR GENETICS AND GENOMICS
  • 2012-07-22 Prediction of Chemotherapy Toxicities in BIOMARKERS IN ONCOLOGY
  • 2012-01-31 Novel Approach for the Development of New Antibodies Directed Against Transposase-Derived Proteins Encoded by Human Neogenes in MOBILE GENETIC ELEMENTS
  • 2011-03-30 Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2009-09-26 Effets vasculaires et rénaux des médicaments anti-angiogéniques: recommandations françaises pour la pratique in ONCOLOGIE
  • 2006 Génétique in LES CANCERS DIGESTIFS
  • 2006 Tumeurs rares du tube digestif et du péritoine in LES CANCERS DIGESTIFS
  • 2005-12 Personnalité, représentations et adaptation à la maladie cancéreuse: étude comparative in PSYCHO-ONCOLOGIE
  • 2003-10-14 Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414426.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411119.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417924.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411439.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.12366.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414093.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.493839.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411158.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412370.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15667.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417812.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4444.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411430.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411162.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413756.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.464126.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.50550.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412116.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420032.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418113.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418189.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.139510.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.508487.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411599.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Lecomte", 
        "givenName": "Thierry", 
        "id": "sg:person.01143615757.53", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-5093-0212"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53", 
          "https://orcid.org/0000-0001-5093-0212"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2021-11-01T19:33", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/person/person_877.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01143615757.53'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01143615757.53'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01143615757.53'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01143615757.53'


     

    This table displays all metadata directly associated to this object as RDF triples.

    73 TRIPLES      11 PREDICATES      39 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01143615757.53 schema:affiliation Nd9802f3ce7c8424a902ba10bec78ac77
    2 grid-institutes:grid.12366.30
    3 grid-institutes:grid.139510.f
    4 grid-institutes:grid.14925.3b
    5 grid-institutes:grid.15667.33
    6 grid-institutes:grid.411119.d
    7 grid-institutes:grid.411158.8
    8 grid-institutes:grid.411162.1
    9 grid-institutes:grid.411430.3
    10 grid-institutes:grid.411439.a
    11 grid-institutes:grid.411599.1
    12 grid-institutes:grid.412116.1
    13 grid-institutes:grid.412370.3
    14 grid-institutes:grid.413756.2
    15 grid-institutes:grid.414093.b
    16 grid-institutes:grid.414426.1
    17 grid-institutes:grid.417812.9
    18 grid-institutes:grid.417924.d
    19 grid-institutes:grid.418113.e
    20 grid-institutes:grid.418189.d
    21 grid-institutes:grid.420032.7
    22 grid-institutes:grid.4444.0
    23 grid-institutes:grid.464126.3
    24 grid-institutes:grid.493839.c
    25 grid-institutes:grid.50550.35
    26 grid-institutes:grid.508487.6
    27 grid-institutes:grid.7429.8
    28 schema:familyName Lecomte
    29 schema:givenName Thierry
    30 schema:identifier Nfba7c18c75a14656a6de55a2cc76828f
    31 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143615757.53
    32 https://orcid.org/0000-0001-5093-0212
    33 schema:sdDatePublished 2021-11-01T19:33
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher N5b8fc68097cf4a21ba34d9544308f1ae
    36 sgo:license sg:explorer/license/
    37 sgo:sdDataset persons
    38 rdf:type schema:Person
    39 N5b8fc68097cf4a21ba34d9544308f1ae schema:name Springer Nature - SN SciGraph project
    40 rdf:type schema:Organization
    41 Nd9802f3ce7c8424a902ba10bec78ac77 schema:affiliation grid-institutes:grid.411167.4
    42 sgo:isCurrent true
    43 rdf:type schema:OrganizationRole
    44 Nfba7c18c75a14656a6de55a2cc76828f schema:name orcid_id
    45 schema:value 0000-0001-5093-0212
    46 rdf:type schema:PropertyValue
    47 grid-institutes:grid.12366.30 schema:Organization
    48 grid-institutes:grid.139510.f schema:Organization
    49 grid-institutes:grid.14925.3b schema:Organization
    50 grid-institutes:grid.15667.33 schema:Organization
    51 grid-institutes:grid.411119.d schema:Organization
    52 grid-institutes:grid.411158.8 schema:Organization
    53 grid-institutes:grid.411162.1 schema:Organization
    54 grid-institutes:grid.411167.4 schema:Organization
    55 grid-institutes:grid.411430.3 schema:Organization
    56 grid-institutes:grid.411439.a schema:Organization
    57 grid-institutes:grid.411599.1 schema:Organization
    58 grid-institutes:grid.412116.1 schema:Organization
    59 grid-institutes:grid.412370.3 schema:Organization
    60 grid-institutes:grid.413756.2 schema:Organization
    61 grid-institutes:grid.414093.b schema:Organization
    62 grid-institutes:grid.414426.1 schema:Organization
    63 grid-institutes:grid.417812.9 schema:Organization
    64 grid-institutes:grid.417924.d schema:Organization
    65 grid-institutes:grid.418113.e schema:Organization
    66 grid-institutes:grid.418189.d schema:Organization
    67 grid-institutes:grid.420032.7 schema:Organization
    68 grid-institutes:grid.4444.0 schema:Organization
    69 grid-institutes:grid.464126.3 schema:Organization
    70 grid-institutes:grid.493839.c schema:Organization
    71 grid-institutes:grid.50550.35 schema:Organization
    72 grid-institutes:grid.508487.6 schema:Organization
    73 grid-institutes:grid.7429.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...